XML 55 R40.htm IDEA: XBRL DOCUMENT v3.22.4
Shareholders' Equity (Tables)
12 Months Ended
Dec. 31, 2022
Equity [Abstract]  
Share Repurchase Programs
The following share repurchase programs have been authorized by the Board:
In billions
Authorization Date
AuthorizedRemaining as of
December 31, 2022
November 17, 2022 (“2022 Repurchase Program”)$10.0 $10.0 
December 9, 2021 (“2021 Repurchase Program”)10.0 6.5 
Schedule of Regulatory Requirements The combined statutory net income for the years ended and estimated combined statutory and capital surplus at December 31, 2022, 2021 and 2020 for the Company’s insurance and HMO subsidiaries were as follows:
In millions202220212020
Statutory net income
$2,851 $3,302 $3,667 
Estimated statutory capital and surplus
15,503 14,879 13,238 
Statutory Accounting Practices Disclosure At December 31, 2022, these amounts were as follows:
In millions
Estimated minimum statutory surplus required by regulators$7,741 
Investments on deposit with regulatory bodies652 
Estimated maximum dividend distributions permitted in 2023 without prior regulatory approval2,706